IMMUNATE S/D subst sèche 500 UI cum solv flac

7680527150247 CH-52715 B02BD06 06.01.1.

Reimbursement limitations:

BLUTPRODUKTE

Calcul des prix des préparations sanguines sur la base du prix « ex factory », …

IMMUNATE S/D subst sèche 500 UI cum solv flac
IMMUNATE S/D subst sèche 500 UI cum solv flac
IMMUNATE S/D subst sèche 500 UI cum solv flac
1 / 3
google

Details

Product number
5271505
CPT
-
Packaging group
500
Unit
I.E.
Composition
Praeparatio cryodesiccata: factor VIII coagulationis humanus 500 U.I., corresp. Specific activity (albumin-corrected) 70 ± 30 U.I. pro proteina 1 mg, corresp. von Willebrand factor activity (VWF:CBA) ca. 75 U.I./ml. albuminum humanum, glycinum, lysini hydrochloridum 25 mg, natrii chloridum, natrii citras dihydricus, calcii chloridum dihydricum, pro vitro corresp. natrium ca. 9.8 mg. Solvens: aqua ad iniectabile, pro vitro corresp. in solutione recenter reconstituta 100 U.I./ml.

Articles (1)

Immunate S/D 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
500
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/04/2024
Professional SmPC
Français
18/04/2024
Professional SmPC
Italien
18/04/2024

Detailed composition

Substance Quantity Type Category
PRC
500.0 UI Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
PRC
1.0 MG Substance WIZUS
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
25.0 MG Substance WIZUS
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HBESI

Reimbursement information

Public price
CHF 410.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1996

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
52715
Drug name
Immunate S/D, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
LSPA
ATC Code
B02BD06
Authorization status
Z
Dispensation category
B
First authorization
24/08/1995
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Hämophilie A (angeborener Faktor VIII-Mangel) Faktor VIII Mangel Prophylaxe und Therapie von Blutungen bei Hämophilie A und beim von Willebrand Syndrom

Packaging details

Description (FR)
IMMUNATE S/D subst sèche 500 UI cum solv flac
Description (DE)
IMMUNATE S/D Trockensub 500 IE cum Solv Durchstf
Market launch
01/01/2005
Narcotic (BTM)
No

Application methods

IV

Other packaging sizes

IMMUNATE S/D subst sèche 250 UI cum solv flac
250 IE
View
IMMUNATE S/D subst sèche 1000 UI cum solv flac
1000 IE
View